Community-Acquired Pneumonia

2014/10/22 by Daniel M. Musher, Anna R. Thorner · 4 citations
Medicine · #Pneumonia and Respiratory Infections #Respiratory viral infections research #Pneumocystis jirovecii pneumonia detection and treatment

paper · doi:10.1056/nejmra1312885

Abstract

Community-acquired pneumonia is a commonly diagnosed illness in which no causative organism is identified in half the cases. Application of molecular diagnostic techniques has the potential to lead to more targeted therapy in the face of increasing antibiotic resistance.

Citations

• A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia

Cited by

• Real-word utility of procalcitonin in patients hospitalized with community-acquired pneumonia: A matched cohort study
• Bacterial pneumonia induces senescence in resident alveolar macrophages that are outcompeted by monocytes
• Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
• Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia

Related

• Community-Acquired Pneumonia
• Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline
• The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia
• The Challenging Diagnosis of Non-Community-Acquired Pneumonia in Non-Mechanically Ventilated Subjects: Value of Microbiological Investigation
• Incidence of Community-Acquired Pneumonia Requiring Hospitalization